Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 155 points (-1.0%) at 15,255 as of Wednesday, May 29, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 466 issues advancing vs. 2,548 declining with 68 unchanged. The Services sector currently sits down 0.96 versus the S&P 500, which is down 0.89. On the negative front, top decliners within the sector include Companhia Brasileira De Distribuicao ( CBD), down 4.10, Delta Air Lines ( DAL), down 3.69, Luxottica Group ( LUX), down 2.81, McKesson ( MCK), down 2.52 and Genuine Parts Company ( GPC), down 2.61. TheStreet Ratings group would like to highlight 5 stocks pushing the sector lower today: 5. CVS Caremark ( CVS) is one of the companies pushing the Services sector lower today. As of noon trading, CVS Caremark is down $0.93 (-1.5%) to $59.28 on light volume Thus far, 1.9 million shares of CVS Caremark exchanged hands as compared to its average daily volume of 5.7 million shares. The stock has ranged in price between $59.06-$59.88 after having opened the day at $59.83 as compared to the previous trading day's close of $60.21. CVS Caremark Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. CVS Caremark has a market cap of $72.5 billion and is part of the retail industry. The company has a P/E ratio of 18.4, above the S&P 500 P/E ratio of 17.7. Shares are up 24.5% year to date as of the close of trading on Tuesday. Currently there are 14 analysts that rate CVS Caremark a buy, no analysts rate it a sell, and 1 rates it a hold. TheStreet Ratings rates CVS Caremark as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CVS Caremark Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.